Form 4: Astera Labs CEO Jitendra Mohan Sells Shares Under 10b5-1 Trading Plan

Astera Labs CEO Jitendra Mohan sold shares of the company's common stock on October 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On October 1, 2024, Jitendra Mohan, CEO of Astera Labs, Inc., sold shares of the company's common stock.
• The sales were executed automatically under a Rule 10b5-1 trading plan adopted on May 31, 2024.
• A total of 95,452 shares were sold at a weighted average price of $51.4933 per share.
• The sales were conducted in multiple transactions with prices ranging from $50.60 to $52.75.
• Following the transactions, Mohan continues to beneficially own a significant number of shares directly and indirectly through various trusts.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a routine stock sale under a pre-existing trading plan. There's no indication of positive or negative implications for the company's performance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information. The impact on the stock price is usually minimal unless the sales are unusually large or frequent.

Comparison to Industry Standards

• Comparing this to other tech company CEOs, the use of 10b5-1 plans is standard practice.
• For example, executives at companies like NVIDIA and AMD also utilize these plans for regular stock sales.
• The size of the sale (95,452 shares) is relatively small compared to the total outstanding shares and is unlikely to cause significant market disruption.
• Similar filings from executives at comparable companies like Marvell Technology and Broadcom can be reviewed to understand typical insider trading patterns.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares, but the effect is likely to be minimal given the relatively small size of the transaction and the pre-planned nature of the sale.
• The impact on employees, customers, suppliers, and creditors is expected to be negligible.

Key Dates